In order to overcome this defect, experts have developed a corresponding antibody-specific anti-GPC3 monoclonal (Anti-GPC3 Ab) through the relatively specific expression molecule glypican-3 (GPC3) of liver cancer. The gene discussed is GPC3; the disease is liver cancer.